Document Classification

Section Type: RESULTS

Text: Compared with the placebo group, the transmitral flow velocities (E/A ratio) (1. 11 + / - 0. 36 versus 0. 85 + / - 0. 24, p < 0. 01) and the myocardial motion velocities (Em/Am ratio) at the septal mitral annulus (0. 90 + / - 0. 19 versus 0. 70 + / - 0. 18, p < 0. 05) and the lateral mitral annulus (1. 06 + / - 0. 20 versus 0. 86 + / - 0. 14, p < 0. 01) were significantly increased, while there was no significant change in the LV wall thickness after 72 weeks of therapy with Xuezhikang.